Why would they Novartis leave, when the treatment works, they looking forward more exposure to regenerative therapies, and reduces the mortality rates and reduces inflammation across critical organs.
- Forums
- ASX - By Stock
- MSB
- Ann: Mesoblast Operational Highlights and Upcoming Milestones
Ann: Mesoblast Operational Highlights and Upcoming Milestones, page-45
-
-
- There are more pages in this discussion • 133 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.47 |
Change
0.020(1.38%) |
Mkt cap ! $1.684B |
Open | High | Low | Value | Volume |
$1.46 | $1.49 | $1.44 | $2.867M | 1.965M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
11 | 26246 | $1.47 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.48 | 37880 | 11 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
10 | 45312 | 1.460 |
8 | 16406 | 1.455 |
8 | 66447 | 1.450 |
5 | 80511 | 1.445 |
4 | 20600 | 1.440 |
Price($) | Vol. | No. |
---|---|---|
1.470 | 22292 | 13 |
1.475 | 69213 | 12 |
1.480 | 201144 | 20 |
1.485 | 94923 | 12 |
1.490 | 85958 | 10 |
Last trade - 15.00pm 21/10/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, Chief Executive Officer
Paul Long
Chief Executive Officer
SPONSORED BY The Market Online